Compare AVAV & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAV | TXG |
|---|---|---|
| Founded | 1971 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.5B |
| IPO Year | 2006 | 2019 |
| Metric | AVAV | TXG |
|---|---|---|
| Price | $154.70 | $84.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 15 |
| Target Price | ★ $316.88 | $20.25 |
| AVG Volume (30 Days) | 2.0M | ★ 2.6M |
| Earning Date | 03-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $135.55 | N/A |
| Revenue Next Year | $14.90 | $7.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $135.20 | $11.17 |
| 52 Week High | $417.86 | $85.93 |
| Indicator | AVAV | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 73.19 |
| Support Level | $138.26 | $56.98 |
| Resistance Level | $165.15 | N/A |
| Average True Range (ATR) | 9.29 | 5.17 |
| MACD | 1.08 | 0.88 |
| Stochastic Oscillator | 54.60 | 93.77 |
AeroVironment Inc is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. The company operates business in two reportable segments: Autonomous Systems (AxS) and Space, Cyber and Directed Energy (SCDE). It derives majority of revenue from Autonomous Systems segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. Geographically it derives the majority of revenue from domestic operations.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).